Faruqi & Faruqi Reminds Alarum Technologies Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 – ALARFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Alarum To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Alarum Technologies Ltd. and Certain Officers – ALARNEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Alarum Technologies Ltd. (“Alarum” or the “Company”) (
NASDAQ: ALAR) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-01263, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Alarum securities between March 14, 2024 and August 26, 2024, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics, Alarum, and Merck and Encourages Investors to Contact the FirmNEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of FMC Corporation (
NYSE:FMC), TransMedics Group, Inc. (
NASDAQ:TMDX), Alarum Technologies Ltd. (
NASDAQ: ALAR), and Merck & Co., Inc. (
NYSE: MRK). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlarumFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alarum To Contact Him Directly To Discuss Their Options
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlarumFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alarum To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlarumFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Alarum To Contact Him Directly To Discuss Their Options
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlarumFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Alarum To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Trade Desk, TransMedics, Alarum, and Constellation and Encourages Investors to Contact the FirmNEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of The Trade Desk, Inc. (
NASDAQ:TTD), TransMedics Group, Inc. (
NASDAQ:TMDX), Alarum Technologies Ltd. (
NASDAQ: ALAR), and Constellation Brands, Inc. (
NYSE:STZ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
ALAR INVESTORS: Contact Robbins LLP for Information About the Lead Plaintiff Deadline in Securities Class Action Against Alarum Technologies, Inc.SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired Alarum Technologies Ltd. (
NASDAQ: ALAR) securities between March 14, 2024 and August 26, 2024. Alarum is a global Software as a Service (“SaaS”) provider that offers web data collection solutions and a private internet browsing platform to a concentrated customer base.
ALAR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Alarum Technologies Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Alarum Technologies Ltd. (“Alarum” or “the Company”) (
NASDAQ: ALAR) and certain of its officers.
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlarumFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Alarum To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics, Alarum, and Constellation and Encourages Investors to Contact the FirmNEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of FMC Corporation (
NYSE:FMC), TransMedics Group, Inc. (
NASDAQ:TMDX), Alarum Technologies Ltd. (
NASDAQ: ALAR), and Constellation Brands, Inc. (
NYSE:STZ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Deadline Alert: Alarum Technologies Ltd. (ALAR) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP reminds investors of the upcoming April 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Alarum Technologies Ltd. (“Alarum” or the “Company”) (
NASDAQ: ALAR) securities between March 14, 2024 and August 26, 2024, inclusive (the “Class Period”).
Deadline Approaching: Alarum Technologies Ltd. (ALAR) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming April 15, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Alarum Technologies Ltd. (“Alarum” or the “Company”) (
NASDAQ: ALAR) securities between March 14, 2024 and August 26, 2024, inclusive (the “Class Period”).
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Alarum Technologies Ltd. (ALAR) Investors To Inquire About Securities Fraud Class Action
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Alarum Technologies Ltd. (“Alarum” or the “Company”) (
NASDAQ: ALAR) securities between March 14, 2024 and August 26, 2024, inclusive (the “Class Period”). Alarum investors have until April 15, 2025 to file a lead plaintiff motion.
ALARUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Alarum Technologies Ltd. and Encourages Investors to Contact the FirmNEW YORK , Feb. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Alarum Technologies Ltd. (“Alarum” or the “Company”) (
NASDAQ: ALAR) in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired Alarum securities between March 14, 2024 and August 26, 2024, both dates inclusive (the “Class Period”). Investors have until April 15, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
